THYROID GLAND ANAPLASTIC CARCINOMA
Clinical trials for THYROID GLAND ANAPLASTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND ANAPLASTIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND ANAPLASTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets Hard-to-Treat cancers in first human study
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have a specific marker called CD44v6 and have stopped responding to standard treatments. The main g…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New combo attack on deadly thyroid cancer shows early promise
Disease control Recruiting nowThis early-stage trial tests whether adding two targeted drugs (dabrafenib and trametinib) to standard radiation therapy can better treat a rare and fast-growing thyroid cancer called anaplastic thyroid cancer that has a specific gene change (BRAF mutation). The study involves 6 …
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC